Citation APA
Thieblemont, C., Howlett, S., Casasnovas, R. O., Mounier, N., Perrot, A., Morschhauser, F., Fruchart, C., Daguindau, N., Van Eygen, K., Obéric, L., Bouabdallah, R., Pica, G. M., Nicolas-Virezelier, E., Abraham, J., Fitoussi, O., Snauwaert, S., Eisenmann, J. C., Lionne-Huyghe, P., Bron, D., Tricot, S., Deeren, D., Gonzalez, H., Costello, R., Le Du, K., Da Silva, M. G., Grosicki, S., Trotman, J., Catalano, J., Caballero, D., Greil, R., Cohen, A. A., Gaulard, P., Roulin, L., Takeshita, K., Casadebaig, M. L., Tilly, H., & Coiffier, B. (2019). Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study. British journal of haematology. doi:10.1111/bjh.16300
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296793